Ascites epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
The [[incidence]] of ascites is approximately 60,000 per 100,000 individuals with [[cirrhosis]] worldwide. The [[incidence]] of ascites is approximately 75,000 per 100,000 [[Cirrhosis|cirrhotic]] individuals with a [[mortality rate]] of 50%, within 3 years. Patients of all age groups may develop ascites. [[Cirrhosis|Cirrhotic]] ascites usually affects individuals of the non-Hispanic blacks and Mexican Americans race. Males are more commonly affected by [[Cirrhosis|cirrhotic]] ascites than females. The male to female ratio is approximately 2.5 to 1. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of ascites is approximately 60,000 per 100,000 individuals with cirrhosis worldwide.<ref name="pmid3804191">{{cite journal |vauthors=Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, Caballería J, Rodés J, Rozman C |title=Compensated cirrhosis: natural history and prognostic factors |journal=Hepatology |volume=7 |issue=1 |pages=122–8 |year=1987 |pmid=3804191 |doi= |url=}}</ref> | *The [[incidence]] of ascites is approximately 60,000 per 100,000 individuals with [[cirrhosis]] worldwide.<ref name="pmid3804191">{{cite journal |vauthors=Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, Caballería J, Rodés J, Rozman C |title=Compensated cirrhosis: natural history and prognostic factors |journal=Hepatology |volume=7 |issue=1 |pages=122–8 |year=1987 |pmid=3804191 |doi= |url=}}</ref> | ||
* | *Among patients with ascites 8,000 to 35,000 per 100,000 individuals would involve in [[Spontaneous bacterial peritonitis|spontaneous bacterial peritonitis (SBP)]].<ref name="pmid8228129">{{cite journal |vauthors=Caly WR, Strauss E |title=A prospective study of bacterial infections in patients with cirrhosis |journal=J. Hepatol. |volume=18 |issue=3 |pages=353–8 |year=1993 |pmid=8228129 |doi= |url=}}</ref> | ||
* | *The [[incidence]] of [[chylous ascites]] is approximately 5 per 100,000 individuals worldwide.<ref name="pmid7059101">{{cite journal |vauthors=Press OW, Press NO, Kaufman SD |title=Evaluation and management of chylous ascites |journal=Ann. Intern. Med. |volume=96 |issue=3 |pages=358–64 |year=1982 |pmid=7059101 |doi= |url=}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
*The | *The [[prevalence]] of ascites is approximately 75,000 per 100,000 individuals with [[cirrhosis]] in Western countries.<ref name="pmid25954497">{{cite journal| author=Pedersen JS, Bendtsen F, Møller S| title=Management of cirrhotic ascites. | journal=Ther Adv Chronic Dis | year= 2015 | volume= 6 | issue= 3 | pages= 124-37 | pmid=25954497 | doi=10.1177/2040622315580069 | pmc=4416972 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25954497 }}</ref> | ||
* | *The [[prevalence]] of [[cirrhosis]], [[malignancy]], [[heart failure]], [[tuberculosis]], and [[nephrotic syndrome]] is approximately 81,000, 10,000, 3,000, 2,000, and 1,000 per 100,000 individuals with ascites worldwide, respectively.<ref name="pmid1616215">{{cite journal |vauthors=Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG |title=The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites |journal=Ann. Intern. Med. |volume=117 |issue=3 |pages=215–20 |year=1992 |pmid=1616215 |doi= |url=}}</ref> | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
* | *The [[incidence]] of ascites is approximately 75,000 per 100,000 [[Cirrhosis|cirrhotic]] individuals with a [[mortality rate]] of 50%, within 3 years.<ref name="pmid11211907">{{cite journal |vauthors=Fernández-Esparrach G, Sánchez-Fueyo A, Ginès P, Uriz J, Quintó L, Ventura PJ, Cárdenas A, Guevara M, Sort P, Jiménez W, Bataller R, Arroyo V, Rodés J |title=A prognostic model for predicting survival in cirrhosis with ascites |journal=J. Hepatol. |volume=34 |issue=1 |pages=46–52 |year=2001 |pmid=11211907 |doi= |url=}}</ref> | ||
* | *[[Survival rate|Survival]] from ascites majorly depends on severity of [[portal hypertension]], [[liver failure]], and [[circulation]] dysfunction.<ref name="pmid25954497" /> | ||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop | *Patients of all age groups may develop ascites. | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to | *There is no [[racial]] predilection to ascites. | ||
*[ | *[[Cirrhosis|Cirrhotic]] ascites usually affects individuals of the non-Hispanic blacks and Mexican Americans race.<ref name="pmid25291348">{{cite journal |vauthors=Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, Volk ML |title=The Epidemiology of Cirrhosis in the United States: A Population-based Study |journal=J. Clin. Gastroenterol. |volume=49 |issue=8 |pages=690–6 |year=2015 |pmid=25291348 |doi=10.1097/MCG.0000000000000208 |url=}}</ref> | ||
===Gender=== | ===Gender=== | ||
* | *Ascites affects men and women equally. | ||
* | *Males are more commonly affected by [[Cirrhosis|cirrhotic]] ascites than females. The male to female ratio is approximately 2.5 to 1.<ref name="pmid25291348" /> | ||
===Region=== | ===Region=== | ||
* | *[[Cirrhosis|Cirrhotic]] ascites is a common disease that tends to affect people below the poverty and with low education level.<ref name="pmid25291348" /> | ||
==References== | ==References== | ||
Revision as of 21:08, 15 January 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]
|
Ascites Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ascites epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Ascites epidemiology and demographics |
|
Risk calculators and risk factors for Ascites epidemiology and demographics |
Overview
The incidence of ascites is approximately 60,000 per 100,000 individuals with cirrhosis worldwide. The incidence of ascites is approximately 75,000 per 100,000 cirrhotic individuals with a mortality rate of 50%, within 3 years. Patients of all age groups may develop ascites. Cirrhotic ascites usually affects individuals of the non-Hispanic blacks and Mexican Americans race. Males are more commonly affected by cirrhotic ascites than females. The male to female ratio is approximately 2.5 to 1.
Epidemiology and Demographics
Incidence
- The incidence of ascites is approximately 60,000 per 100,000 individuals with cirrhosis worldwide.[1]
- Among patients with ascites 8,000 to 35,000 per 100,000 individuals would involve in spontaneous bacterial peritonitis (SBP).[2]
- The incidence of chylous ascites is approximately 5 per 100,000 individuals worldwide.[3]
Prevalence
- The prevalence of ascites is approximately 75,000 per 100,000 individuals with cirrhosis in Western countries.[4]
- The prevalence of cirrhosis, malignancy, heart failure, tuberculosis, and nephrotic syndrome is approximately 81,000, 10,000, 3,000, 2,000, and 1,000 per 100,000 individuals with ascites worldwide, respectively.[5]
Case-fatality rate/Mortality rate
- The incidence of ascites is approximately 75,000 per 100,000 cirrhotic individuals with a mortality rate of 50%, within 3 years.[6]
- Survival from ascites majorly depends on severity of portal hypertension, liver failure, and circulation dysfunction.[4]
Age
- Patients of all age groups may develop ascites.
Race
- There is no racial predilection to ascites.
- Cirrhotic ascites usually affects individuals of the non-Hispanic blacks and Mexican Americans race.[7]
Gender
- Ascites affects men and women equally.
- Males are more commonly affected by cirrhotic ascites than females. The male to female ratio is approximately 2.5 to 1.[7]
Region
- Cirrhotic ascites is a common disease that tends to affect people below the poverty and with low education level.[7]
References
- ↑ Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, Caballería J, Rodés J, Rozman C (1987). "Compensated cirrhosis: natural history and prognostic factors". Hepatology. 7 (1): 122–8. PMID 3804191.
- ↑ Caly WR, Strauss E (1993). "A prospective study of bacterial infections in patients with cirrhosis". J. Hepatol. 18 (3): 353–8. PMID 8228129.
- ↑ Press OW, Press NO, Kaufman SD (1982). "Evaluation and management of chylous ascites". Ann. Intern. Med. 96 (3): 358–64. PMID 7059101.
- ↑ 4.0 4.1 Pedersen JS, Bendtsen F, Møller S (2015). "Management of cirrhotic ascites". Ther Adv Chronic Dis. 6 (3): 124–37. doi:10.1177/2040622315580069. PMC 4416972. PMID 25954497.
- ↑ Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG (1992). "The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites". Ann. Intern. Med. 117 (3): 215–20. PMID 1616215.
- ↑ Fernández-Esparrach G, Sánchez-Fueyo A, Ginès P, Uriz J, Quintó L, Ventura PJ, Cárdenas A, Guevara M, Sort P, Jiménez W, Bataller R, Arroyo V, Rodés J (2001). "A prognostic model for predicting survival in cirrhosis with ascites". J. Hepatol. 34 (1): 46–52. PMID 11211907.
- ↑ 7.0 7.1 7.2 Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, Volk ML (2015). "The Epidemiology of Cirrhosis in the United States: A Population-based Study". J. Clin. Gastroenterol. 49 (8): 690–6. doi:10.1097/MCG.0000000000000208. PMID 25291348.